Quan Capital
34
66M
24
4.86
4
0.29
4
- Stages of investment
- Areas of investment
Summary
In 2017 was created Quan Capital, which is appeared as VC. The venture was found in Asia in China. The main office of represented VC is situated in the Shanghai.
The overall number of key employees were 3.
Among the most popular portfolio startups of the fund, we may highlight ARMO BioSciences, Centrexion, Tempest Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Biotechnology, Mobile Apps.
The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Quan Capital, startups are often financed by OrbiMed, Kleiner Perkins, DAG Ventures. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Takeda Ventures, Qiming Venture Partners. In the next rounds fund is usually obtained by EFung Capital.
The average startup value when the investment from Quan Capital is 100-500 millions dollars. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in 2-6 investment rounds annually. This Quan Capital works on 9 percentage points more the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2019. Considering the real fund results, this VC is 18 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2018.
Investments analytics
Analytics
- Total investments
- 34
- Lead investments
- 4
- Exits
- 4
- Rounds per year
- 4.86
- Follow on index
- 0.29
- Investments by industry
- Biotechnology (21)
- Pharmaceutical (19)
- Health Care (15)
- Biopharma (12)
- Medical (7) Show 16 more
- Investments by region
-
- United States (17)
- China (15)
- United Kingdom (2)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 75M
- Group Appearance index
- 0.97
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| MEDx | 28 Sep 2020 | Early Stage Venture | 54M | Jiangsu, Suzhou, China | |
| Yuanyin Bio | 20 Jun 2022 | Biotechnology, Medical, Pharmaceutical, Biopharma | Early Stage Venture | 42M | Beijing, Haidian, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.